Evidence map›Paper›PMID 30457979›Full record

ArticleThe Journal of clinical investigation2019

Spec-seq unveils transcriptional subpopulations of antibody-secreting cells following influenza vaccination.

Karlynn E Neu, Jenna J Guthmiller, Min Huang, Jennifer La, Marcos C Vieira, Kangchon Kim, Nai-Ying Zheng, Mario Cortese, Micah E Tepora, Natalie J Hamel and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 47 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

Karlynn E NeuThe Committee on Immunology.
Jenna J GuthmillerThe Department of Medicine, Section of Rheumatology.
Min HuangThe Department of Medicine, Section of Rheumatology.
Jennifer LaThe Department of Pathology, Molecular Pathogenesis and Molecular Medicine, and.
Marcos C VieiraThe Department of Ecology and Evolution, The University of Chicago, Chicago, Illinois, USA.
Kangchon KimThe Department of Ecology and Evolution, The University of Chicago, Chicago, Illinois, USA.
Nai-Ying ZhengThe Department of Medicine, Section of Rheumatology.
Mario CorteseEmory Vaccine Center, Emory University, Atlanta, Georgia, USA.
Micah E TeporaThe Committee on Immunology.
Natalie J HamelThe Committee on Immunology.
Karla Thatcher RojasThe Department of Medicine, Section of Rheumatology.
Carole HenryThe Department of Medicine, Section of Rheumatology.
Dustin ShawThe Committee on Immunology.
Charles L DulbergerThe Department of Biochemistry and Molecular Biophysics, The University of Chicago, Chicago, Illinois, USA.
Bali PulendranEmory Vaccine Center, Emory University, Atlanta, Georgia, USA.
Sarah CobeyThe Department of Ecology and Evolution, The University of Chicago, Chicago, Illinois, USA.
Aly A KhanToyota Technological Institute at Chicago, Chicago, Illinois, USA.
Patrick C WilsonThe Committee on Immunology.
Center for Rheumatology · USUniversity of Chicago · USEmory University · USToyota Technological Institute at Chicago · USUniversity of Illinois Chicago · US

Funding

VIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI THOMAS F GAJEWSKI · 1985 to 2026
$122.1M
VACCINE INDUCED IMMUNITY IN THE YOUNG AND AGEDU19AI057266 · NIAID · EMORY UNIVERSITY · PI Rafi Ahmed · 2003 to 2026
$81.7M
Systems Biological Analysis of Innate and Adaptive Responses to VaccinationU19AI090023 · NIAID · EMORY UNIVERSITY · PI AHMED, RAFI, LI, SHUZHAO · 2010 to 2021
$45.0M
MEDICAL SCIENTIST TRAININGT32GM007281 · NIGMS · UNIVERSITY OF CHICAGO · PI CLARK, MARCUS RAMSAY · 1985 to 2022
$32.1M
Toward a Universal Influenza Virus VaccineP01AI097092 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI AHMED, RAFI · 2012 to 2022
$17.6M
INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGYT32AI007090 · NIAID · UNIVERSITY OF CHICAGO · PI Peter Aidan Savage · 1985 to 2026
$11.7M
Understanding Human B Cell Responses to Influenza to Improve the Influenza U19AI109946 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI RAVETCH, JEFFREY VICTOR · 2014 to 2018
$9.6M
University of Chicago Autoimmunity Center of ExcellenceU19AI082724 · NIAID · UNIVERSITY OF CHICAGO · PI WILSON, PATRICK CHRISTOPHER · 2009 to 2023
$7.2M
Emory R38 Research Training ProgramR38AI140299 · NIAID · EMORY UNIVERSITY · PI OFOTOKUN, IGHOVWERHA, ROUPHAEL, NADINE GEORGES · 2018 to 2021
$1.4M
Adaptive immunity in primary sclerosing cholangitis patients at risk for colorectal cancerF30DK121470 · NIDDK · UNIVERSITY OF CHICAGO · PI SHAW, DUSTIN · 2019 to 2022
$203k
NCI NIH HHS P30 CA014599NIAID NIH HHS HHSN272201400005CNIAID NIH HHS P01 AI097092NIAID NIH HHS R38 AI140299NIAID NIH HHS T32 AI007090NIAID NIH HHS U19 AI057266NIAID NIH HHS U19 AI082724NIAID NIH HHS U19 AI090023NIAID NIH HHS U19 AI109946NIDDK NIH HHS F30 DK121470NIGMS NIH HHS T32 GM007281
6 · The paper itself

Abstract

Vaccines are among the most effective public health tools for combating certain infectious diseases such as influenza. The role of the humoral immune system in vaccine-induced protection is widely appreciated; however, our understanding of how antibody specificities relate to B cell function remains limited due to the complexity of polyclonal antibody responses. To address this, we developed the Spec-seq framework, which allows for simultaneous monoclonal antibody (mAb) characterization and transcriptional profiling from the same single cell. Here, we present the first application of the Spec-seq framework, which we applied to human plasmablasts after influenza vaccination in order to characterize transcriptional differences governed by B cell receptor (BCR) isotype and vaccine reactivity. Our analysis did not find evidence of long-term transcriptional specialization between plasmablasts of different isotypes. However, we did find enhanced transcriptional similarity between clonally related B cells, as well as distinct transcriptional signatures ascribed by BCR vaccine recognition. These data suggest IgG and IgA vaccine-positive plasmablasts are largely similar, whereas IgA vaccine-negative cells appear to be transcriptionally distinct from conventional, terminally differentiated, antigen-induced peripheral blood plasmablasts.

Indexed as

VaccinationAntibodies, ViralFemaleHumansImmunoglobulin AImmunoglobulin GInfluenza VaccinesMalePlasma CellsReceptors, Antigen, B-CellTranscription, GeneticAntibodies, ViralImmunoglobulin AImmunoglobulin GInfluenza VaccinesReceptors, Antigen, B-CellAdaptive immunityB cellsImmunologyInfluenzaVaccines

Identifiers

PMID30457979
PMCPMC6307935
OpenAlexW2901000295

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.